To conclude, in a relevant clinical diabetes setting, we have demonstrated increased HDAC3 activity/HDAC3 mRNA levels in patients with type 2 diabetes that was positively correlated to all the inflammatory markers profiled, poor glycemic control, and insulin resistance. The gene discussed is HDAC3; the disease is type 2 diabetes mellitus.